Nilotinib is a potent tyrosine kinase inhibitor primarily used in the treatment of Philadelphia chromosome-positive chronic myeloid leukemia. As a targeted therapy, it functions by inhibiting the BCR-ABL… Read more


































Nilotinib is a potent tyrosine kinase inhibitor primarily used in the treatment of Philadelphia chromosome-positive chronic myeloid leukemia. As a targeted therapy, it functions by inhibiting the BCR-ABL fusion protein to prevent uncontrolled cell division. This category provides essential pharmaceutical reference standards for Nilotinib, supporting laboratories in rigorous analytical testing and quality control. The collection includes a comprehensive range of pharmacopeial and non-pharmacopeial impurities, synthetic intermediates, and degradation products, which are vital for accurate impurity profiling and method validation. Additionally, stable isotope labelled compounds are available to serve as internal standards in quantitative mass spectrometry applications. By offering these well-characterized substances, this catalogue assists researchers and quality control professionals in ensuring regulatory compliance, therapeutic efficacy, and safety throughout the pharmaceutical development and manufacturing lifecycle of the active pharmaceutical ingredient.